Novel Arylalkenylpropargylamines as Neuroprotective, Potent, and Selective Monoamine Oxidase B Inhibitors for the Treatment of Parkinson's Disease

被引：46

作者：

Huleatt, Paul B. ^{[1
]}

Khoo, Mui Ling ^{[1
]}

Chua, Yi Yuan ^{[1
]}

Tan, Tiong Wei ^{[1
]}

Liew, Rou Shen ^{[1
]}

Balogh, Balazs ^{[2
]}

Deme, Ruth ^{[2
]}

Goeloencser, Flora ^{[3
]}

Magyar, Kalman ^{[5
]}

Sheela, David P. ^{[4
]}

Ho, Han Kiat ^{[4
]}

Sperlagh, Beata ^{[3
]}

Matyus, Peter ^{[2
]}

Chai, Christina L. L. ^{[1
,4
]}

机构：

[1] ASTAR, Inst Chem & Engn Sci, Singapore 138665, Singapore

[2] Semmelweis Univ, Dept Organ Chem, H-1092 Budapest, Hungary

[3] Hungarian Acad Sci, Inst Expt Med, Dept Pharmacol, H-1083 Budapest, Hungary

[4] Natl Univ Singapore, Dept Pharm, Singapore 117543, Singapore

[5] Semmelweis Univ, Dept Pharmacodynam, H-1089 Budapest, Hungary

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2015年 / 58卷 / 03期

关键词：

PROTEIN-KINASE-C; COUPLING REACTIONS; IN-VITRO; RASAGILINE; DRUG; CHLORINATION; APOPTOSIS; ISOFORMS; ALKENES; BCL-2;

D O I：

10.1021/jm501722s

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

To develop novel neuroprotective agents, a library of novel arylalkenylpropargylamines was synthesized and tested for inhibitory activities against monoamine oxidases. From this, a number of highly potent and selective monoamine oxidase B inhibitors were identified. Selected compounds were also tested for neuroprotection in in vitro studies with PC-12 cells treated with 6-OHDA and rotenone, respectively. It was observed that some of the compounds tested yielded a marked increase in survival in PC-12 cells treated with the neurotoxins. This indicates that these propargylamines are able to confer protection against the effects of the toxins and may also be considered as novel disease-modifying anti-Parkinsonian agents, which are much needed for the therapy of Parkinson's disease.

引用

页码：1400 / 1419

页数：20

共 31 条

[1] Rasagiline, Parkinson neuroprotection, and delayed-start trials Still no satisfaction?
Ahlskog, J. Eric
Uitti, Ryan J.
[J]. NEUROLOGY, 2010, 74 (14) : 1143 - 1148
[2] Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline
Bar Am, O
Amit, T
Youdim, MBH
[J]. NEUROSCIENCE LETTERS, 2004, 355 (03) : 169 - 172
[3] Regulation of protein kinase C by the anti-Parkinson drug, MAO-B inhibitor, rasagiline and its derivatives, in vivo
Bar-Am, O
Yogev-Falach, M
Amit, T
Sagi, Y
Youdim, MBH
[J]. JOURNAL OF NEUROCHEMISTRY, 2004, 89 (05) : 1119 - 1125
[4] Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro
Bar-Am, Orit
Amit, Tamar
Youdim, Moussa B. H.
[J]. JOURNAL OF NEUROCHEMISTRY, 2007, 103 (02) : 500 - 508
[5] The facile preparation of alkenyl metathesis synthons
Baughman, TW
Sworen, JC
Wagener, KB
[J]. TETRAHEDRON, 2004, 60 (48) : 10943 - 10948
[6] Highly efficient monophosphine-based catalyst for the palladium-catalyzed Suzuki-Miyaura reaction of heteroaryl halides and heteroaryl boronic acids and esters
Billingsley, Kelvin
Buchwald, Stephen L.
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (11) : 3358 - 3366
[7] A new class of easily activated palladium precatalysts for facile C-N cross-coupling reactions and the low temperature oxidative addition of aryl chlorides
Biscoe, Mark R.
Fors, Brett P.
Buchwald, Stephen L.
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (21) : 6686 - +
[8] The lupin alkaloids. Part XII. The synthesis of dl-lupinine and dl-isolupinine
Clemo, GR
Morgan, WM
Raper, R
[J]. JOURNAL OF THE CHEMICAL SOCIETY, 1937, : 965 - 969
[9] CROCE PD, 1990, SYNTHESIS-STUTTGART, P212
[10] GAMMA-FUNCTIONAL VINYLIC GRIGNARD-REAGENTS .1. REACTIVITY OF ORGANOMAGNESIUM COMPOUNDS WITH ALPHA-ACETYLIC ALCOHOLS IN THE PRESENCE OF CUPROUS HALIDES
DUBOUDIN, JG
JOUSSEAUME, B
[J]. JOURNAL OF ORGANOMETALLIC CHEMISTRY, 1979, 168 (01) : 1 - 11

← 1 2 3 4 →